Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

BACKGROUND: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has a wide range of effects on glucose metabolism and cardiovascular function (e.g., improving insulin sensitivity, reduction in appetite, modulation of heart rate, blood pressure and myocardial contractility). Metabolic syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaoka-Tojo, Minako, Tojo, Taiki, Takahira, Naonobu, Matsunaga, Atsuhiko, Aoyama, Naoyoshi, Masuda, Takashi, Izumi, Tohru
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Original investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891690/
https://www.ncbi.nlm.nih.gov/pubmed/20470376
http://dx.doi.org/10.1186/1475-2840-9-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891690/
https://www.ncbi.nlm.nih.gov/pubmed/20470376
http://dx.doi.org/10.1186/1475-2840-9-17

Ejemplares similares